Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPN effect on gene expression in psoriasis skin biopsies
NL-OMON45844Active, not recruiting
- Sponsor
- Derphartox
- Start
- Sep 2018
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of GBS-NN/NN2 vaccine in psoriasis, sponsored by Derphartox. Started Sep 2018; status: active, not recruiting.
02
Drugs
GBS-NN/NN2 vaccine
03
Conditions
psoriasis
Beyond the preview
Go deeper on NL-OMON45844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45844.